UgenTec Revenue and Competitors

Hasselt,

Location

N/A

Total Funding

Analytics

Industry

Estimated Revenue & Valuation

  • UgenTec's estimated annual revenue is currently $1.4M per year.(i)
  • UgenTec's estimated revenue per employee is $84,000

Employee Data

  • UgenTec has 17 Employees.(i)
  • UgenTec grew their employee count by -32% last year.

UgenTec's People

NameTitleEmail/Phone
1
Head Quality and Regulatory AffairsReveal Email/Phone
2
Chief Operations OfficerReveal Email/Phone
3
Support ManagerReveal Email/Phone
4
Team Lead / Project ManagerReveal Email/Phone
5
Product managerReveal Email/Phone
6
Customer Success ManagerReveal Email/Phone
7
Information Security ManagerReveal Email/Phone
8
Senior Quality ManagerReveal Email/Phone
9
Assay Plugin DeveloperReveal Email/Phone
10
Software EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M90-36%$14.1MN/A
#2
$83.2M468-3%$251MN/A
#3
$14M1001%N/AN/A
#4
$14.6M0N/A$12.5MN/A
#5
$30.3M197-6%N/AN/A
#6
$0.1M6-25%$2.6MN/A
#7
$45.1M2932%N/AN/A
#8
$4.8M43-7%N/AN/A
#9
$399.3M203740%N/AN/A
#10
$44M2864%N/AN/A
Add Company

What Is UgenTec?

UgenTec is a molecular laboratory software provider servicing molecular labs, assay and instrument providers globally across applications in Clinical Molecular Diagnostics, Veterinary health, Crop Science, Breeding and Seed Health. UgenTec is headquartered in Hasselt, Belgium with offices in Boston, MA and its FastFinder platform has a global installed base of over 100 molecular labs and partnerships with leading molecular diagnostics vendors. FastFinder is a modular, clinical grade Software as a Service platform using AI methods allowing labs of all sizes to standardize and automate their molecular workflows. FastFinder's modules include Analysis, Genotyper and Workflow.

keywords:N/A

N/A

Total Funding

17

Number of Employees

$1.4M

Revenue (est)

-32%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.3M3043%N/A
#2
$5.5M3431%N/A
#3
$9.5M3633%N/A
#4
$4M360%N/A
#5
$6.3M4476%N/A